Literature DB >> 10325271

Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies.

E Camus1, C Poncelet, F Goffinet, B Wainer, F Merlet, I Nisand, H J Philippe.   

Abstract

This meta-analysis was intended to evaluate differences in pregnancy rates after in-vitro fertilization (IVF) in tubal fertility with and without hydrosalpinx. It examined nine published retrospective comparative series and five series published as abstracts for which additional information was obtained. In all, these studies involved 5592 patients (1004 with hydrosalpinx and 4588 with tubal infertility without hydrosalpinx). The main outcome measures were rates of pregnancy, implantation, live delivery, and early pregnancy loss. Pregnancy rates were significantly lower in the presence of hydrosalpinx: 31.2% for the tubal sterility group without hydrosalpinx and 19.7% for the group with hydrosalpinx (odds ratio: 0.64; 95% confidence interval: 0.56, 0.74). Similarly, the implantation rate and the delivery rate per transfer in the hydrosalpinx group were only slightly more than half those of the non-hydrosalpinx group (implantation: 8.5 and 13.7%, respectively; delivery: 13.4 and 23.4%). The incidence of early pregnancy loss was also higher in the hydrosalpinx group (43.7%) than in the control group (31.1%). This meta-analysis makes it clear that hydrosalpinx present during IVF-embryo transfer has negative consequences on the rates of pregnancy, implantation, live delivery, and early pregnancy loss. It would be premature, nonetheless, to conclude that routine salpingectomy should be performed on all patients with hydrosalpinx.

Entities:  

Mesh:

Year:  1999        PMID: 10325271     DOI: 10.1093/humrep/14.5.1243

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

1.  Ovarian response to gonadotropin stimulation in repeated IVF cycles after unilateral salpingectomy.

Authors:  Joseph Tal; Yoav Paltieli; Roman Korobotchka; Genia Ziskind; Izu Eibschitz; Gonen Ohel
Journal:  J Assist Reprod Genet       Date:  2002-10       Impact factor: 3.412

2.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

Review 3.  Implantation failure: molecular mechanisms and clinical treatment.

Authors:  Hakan Cakmak; Hugh S Taylor
Journal:  Hum Reprod Update       Date:  2010-08-21       Impact factor: 15.610

4.  Pregnancy after hydrosalpinx treatment with Essure.

Authors:  Gonçalo Inocêncio; Lúcia Coutinho; Raquel Maciel; Márcia Barreiro
Journal:  BMJ Case Rep       Date:  2013-03-26

5.  Trends and correlates of good perinatal outcomes in assisted reproductive technology.

Authors:  Nikhil Joshi; Dmitry Kissin; John E Anderson; Donna Session; Maurizio Macaluso; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

6.  Effect of endometrial cavity fluid on clinical pregnancy rate in tubal embryo transfer (TET).

Authors:  Robert Kuo-Kuang Lee; San-Li Yu; Yu-Fen Chih; Yi-Chun Tsai; Ming-Huei Lin; Yuh-Ming Hwu; Wen-Yu Huang; Jin-Tsung Su
Journal:  J Assist Reprod Genet       Date:  2006-05       Impact factor: 3.412

7.  State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; G Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2014-03-24       Impact factor: 3.828

Review 8.  Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Authors:  Neil Johnson; Sabine van Voorst; Martin C Sowter; Annika Strandell; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women.

Authors:  A Kinnunen; H-M Surcel; M Halttunen; A Tiitinen; R P Morrison; S G Morrison; P Koskela; M Lehtinen; J Paavonen
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

10.  Uterine aquaporin expression is dynamically regulated by estradiol and progesterone and ovarian stimulation disrupts embryo implantation without affecting luminal closure.

Authors:  Vanessa de Oliveira; Jennifer Schaefer; Basim Abu-Rafea; George A Vilos; Angelos G Vilos; Moshmi Bhattacharya; Sally Radovick; Andy V Babwah
Journal:  Mol Hum Reprod       Date:  2020-03-26       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.